Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
Media coverage on cancer immunotherapy has generally struck an excited note. This week, the TV program 60 Minutes called immunotherapies "a big ...
Global and USA Cancer Immunotherapy Market Eyes on Revenue Excess of $80 Billion, Finds ... - Digital Journal
Immunotherapy for cancer has been around for some time, but rarely has the results of an idea that seems so far-fetched been this promising. The first ...
Researchers consider this immunotherapy “bifunctional” because it targets a biochemical pathway in cancer cells and it helps stimulate an immune ...
Precision Medicine Some cancer patients are benefiting from drugs that ...Immunotherapy is the fruition of a century-old idea: that a person's own ...
... and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases based on the Arcelis® technology ...
Meanwhile, cancer immunotherapy has been in the spotlight for quite some time now. Several companies are looking to bring immuno-oncology drugs ...
Cancer immunotherapy is the biggest buzz word in cancer R&D in decades, but analyst Amit Roy says that the global market will only be about $10 ...
Immunotherapy is firmly entrenched in the management of patients with advanced melanoma, with various immune checkpoint inhibitors showing ...
scientists discover WHY the disease spreads, paving way for better treatments
British scientists say they have got to the 'root' of prostate cancer
Have exposed an Achilles' heel that could lead to better survival chances
Could mean that men get individualised treatments within a few years
LONDON (Reuters) - A hot new class of drugs designed to help the body's ownimmune system fend off cancer by blocking a protein called PD-1 is ...
Merck & Co., Syndax to Study Cancer Combination ... the immune system's ability to fight cancer in cells that produce the pigment responsible for color ...
Cancer PD-1 inhibitor market only half as large as consensus says analyst - Seeking Alpha (registration)
When people think of treatments for cancer, they likely think of surgery, ... This type of targeted immunotherapy aims to boost the immune system by ...
... therapy in the fight against cancer; one that appears to have the potential to work with the body's natural immune system in the fight against tumors.
... is also developing bispecific immune cell engagers, a class of monoclonal antibodies that direct a person's immune system to attack cancer cells.
Truth about cancer and baking soda
the University of Arizona is now recruiting the first group of patients for a clinical trial. They're treating metastatic breast cancer. One group is getting chemo. The other group is getting chemo plus baking soda, so people ask me, ‘Should I take baking soda prophylactically?'
More than 48,000 people are diagnosed with pancreatic cancer and more than 40,000 will die from the disease each year in th e United States.2.
Brain cancer, also known as glioblastoma, are the last two words any ... of cancer, including breast, prostate, lung, colon, and pancreatic cancers.
Scientists use genetically-engineered polio-virus to cure braincancer, possibly others too - The Standard Daily
Mirati is enrolling patients with CREBBP and EP300 mutations into its Phase II studies of its HDAC inhibitor mocetinostat in bladder cancer and in ...
Diesel exhaust or painting-related lung or bladder cancer are not on the prescribed disease list, nor is welding-related lung cancer. Skin cancer ...
... potentially modifiable risk factors for complications such as poor nutrition is the first step to improving outcomes in surgery for bladder cancer. Next ...
New Era of Bladder Cancer Treatments Has Begun
In this interview we discuss the changing landscape of systemic therapies for the treatment of bladder cancer.
In this interview we discuss the changing landscape of systemic therapies for the treatment of bladder cancer.
Latest News
Stress Management Improved Quality of Life for Breast Cancer Patients
Women who received cognitive behavioral stress management after surgery for early breast cancer reported better quality of life and lower symptoms of depression.
Women who received cognitive behavioral stress management after surgery for early breast cancer reported better quality of life and lower symptoms of depression.
Vitamin D Levels May Be Linked With Follicular Lymphoma Outcomes
Low levels of vitamin D may be associated with poor survival in patients with follicular lymphoma, according to the results of a new analysis.
Low levels of vitamin D may be associated with poor survival in patients with follicular lymphoma, according to the results of a new analysis.
Small Benefit of Follow-Up Imaging in DLBCL Comes With High Costs
Use of routine follow-up imaging to monitor asymptomatic diffuse large B-cell lymphoma patients resulted in a small survival benefit, but at a substantial cost.
Use of routine follow-up imaging to monitor asymptomatic diffuse large B-cell lymphoma patients resulted in a small survival benefit, but at a substantial cost.
Science Daily Cancer News
A new genomic analysis of tissue from patients with prostate cancer has added more evidence that cells within metastases from such tumors can migrate to other body parts and form new sites of spread on their own.
The mechanism that makes fireflies glow through a process called bioluminescence can be used to study tumor response to therapy as well, researchers have found. Bioluminescence has a major role in small animal research, and the technique has been widely applied in tumor models. The multiple tumor approach can also be used for high throughput screening of a vast range of anti-cancer drug therapies.
Scientists have revealed the root of prostate cancers in individual men, discovering that despite huge genetic variety between tumors they also share common gene faults -- insight that could offer new treatment hopes. They also revealed more detail about how prostate cancer spreads, showing that the group of cells that first spread from the prostate carry on traveling around the body, forming more secondary tumors.
An old cancer drug can not only kill cancer cells, but also works to change how certain cancer cells function, weakening those cells so they can be killed by other drugs, a veterinary researcher has discovered.
Imatinib, an example of a 'targeted therapy' against cancer, or related drugs might be tools to fight a variety of infections, scientists say. Imatinib, is an example of a "targeted therapy" against certain types of cancer. It blocks tyrosine kinase enzymes, which are dysregulated in cancers such as chronic myelogenous leukemia and gastrointestinal stromal tumors.
By combining, in a liposome, magnetic nanoparticles and photosensitizers that are simultaneously and remotely activated by external physical stimuli (a magnetic field and light), scientists obtained total tumor regression in mice. Non-toxic when they are not activated, such therapies can also achieve a reduction in adverse effects. These results demonstrate the importance of multiple treatments.
The prevalence of childhood cancer survivors is estimated to have increased, and the majority of those who have survived five or more years beyond diagnosis may have at least one chronic health condition, a new report suggests.
While there has been substantial progress in some cancer control efforts in the past several decades, like reductions in smoking and increased utilization of cancer screening, progress in some areas is lagging in the United States, according to a new report.
Tambahkan Komentar